Most Viewed Articles on HIV/AIDS
ART Works. But Researchers are Pursuing a Cure for HIV.
Results of a small study published in Nature Medicine show that early treatment with a monoclonal antibody might be part of a strategy to clear an HIV infection.
Positive Findings for Biktarvy Presented at HIV Research Meeting in Glasgow
Gilead Sciences reported results from several studies of its antiretroviral.
HIV Prevention, Treatment: Playing the Long Game
Drug manufacturers are developing long-acting, injectable HIV drugs for both treatment and prevention.
HIV Vaccine Trial Utilizing mRNA Underway
The decades-long quest for a vaccine against HIV has been fruitless so far. Moderna hopes an HIV vaccine that uses its messenger RNA technology will break the losing streak. A phase 1 trial designed to include 56 volunteers has started.
They Are Still There, Large and Looming: Barriers to HIV Testing and Care.
In a conversation with Managed Healthcare Executive®, Genoa Healthcare Sales Director Jennifer Finocchiaro discusses social determinants of health, the LGBTQ+ community and the demographic contours of the HIV/AIDS epidemic.
Study of New Orleans Neighborhoods, Time to Viral Suppression, Shows Long Shadow of Redlining
October 7th 2024People living with HIV in neighborhoods that had been redlined by federal housing officials had a longer time interval between HIV diagnosis and achievement of viral suppression, a marker of successful treatment and access to healthcare, according to findings published in JAMA Internal Medicine.
Read More
